GB Patent

GB9514451D0 — Sustained-release formulation

Assigned to Chirotech Technology Ltd · Expires 1995-09-13 · 31y expired

What this patent protects

The subject invention pertains to a sustained-release formulation of d-threo-methylphenidate (dtmp). The subject invention also pertains to methods for treating disorders using a sustained-release formulation comprising d-threo-methylphenidate.

USPTO Abstract

The subject invention pertains to a sustained-release formulation of d-threo-methylphenidate (dtmp). The subject invention also pertains to methods for treating disorders using a sustained-release formulation comprising d-threo-methylphenidate.

Drugs covered by this patent

Patent Metadata

Patent number: GB9514451D0
Jurisdiction: GB
Classification: —
Expires: 1995-09-13
Drug substance claim: No
Drug product claim: No
Assignee: Chirotech Technology Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.